NCT07514793 2026-04-07
Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
Fudan University
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07131345 2025-08-20
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
National Cancer Center, China
Phase 1/2 Not yet recruiting
NCT06310993 2024-12-03
BICEP
Sheffield Teaching Hospitals NHS Foundation Trust
Phase NA Not yet recruiting
NCT06652529 2024-11-07
AROG4-01-01
Aromics Therapeutics
Phase 1 Not yet recruiting
NCT05819580 2023-04-25
Studying the Clinical Trial Experiences of Patients With Mesothelioma
Power Life Sciences Inc.
Not yet recruiting